ID

26741

Description

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00880009

Lien

https://clinicaltrials.gov/show/NCT00880009

Mots-clés

Versions (1)
  1. 23/10/2017 23/10/2017 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

23 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT00880009

Anglais

Eligibility Breast Cancer NCT00880009

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
surgically sterile or post-menopausal women.
Description

Female Sterilization | Postmenopausal state

Type de données

boolean

Alias
UMLS CUI [1]
C0015787
UMLS CUI [2]
C0232970
confirmed pathologic diagnosis of breast cancer.
Description

Breast Carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0678222
locally advanced or metastatic, or loco-regional recurrent breast cancer not amenable to curative treatment with surgery or radiotherapy.
Description

Locally advanced breast cancer | Secondary malignant neoplasm of female breast | Breast cancer recurrent Local-Regional | Curative Surgery Unsuccessful | Therapeutic radiology procedure Curative Unsuccessful

Type de données

boolean

Alias
UMLS CUI [1]
C3495949
UMLS CUI [2]
C0346993
UMLS CUI [3,1]
C0278493
UMLS CUI [3,2]
C1947913
UMLS CUI [4,1]
C1511562
UMLS CUI [4,2]
C1272705
UMLS CUI [5,1]
C1522449
UMLS CUI [5,2]
C1276305
UMLS CUI [5,3]
C1272705
documented er+ and/or pgr+ and erbb2- tumor based on most recently analyzed biopsy, as documented by a local laboratory.
Description

Estrogen receptor positive tumor Biopsy | Progesterone receptor positive tumor Biopsy | Neoplasm HER2/Neu Negative Biopsy

Type de données

boolean

Alias
UMLS CUI [1,1]
C1562312
UMLS CUI [1,2]
C0005558
UMLS CUI [2,1]
C1562928
UMLS CUI [2,2]
C0005558
UMLS CUI [3,1]
C0027651
UMLS CUI [3,2]
C2348908
UMLS CUI [3,3]
C0005558
at least 1 radiologically measurable lesion as defined by response evaluation criteria in solid tumors (recist).
Description

Measurable lesion Quantity Radiography

Type de données

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0043299
eastern cooperative oncology group (ecog) performance status 0-2.
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior letrozole (except in adjuvant setting), prior bosutinib, or any other prior src inhibitor.
Description

letrozole | Exception Adjuvant therapy | bosutinib | src inhibitors

Type de données

boolean

Alias
UMLS CUI [1]
C0246421
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0677850
UMLS CUI [3]
C1831731
UMLS CUI [4,1]
C0282625
UMLS CUI [4,2]
C0243077
prior endocrine treatment for locally advanced or metastatic breast cancer (up to one prior adjuvant aromatase inhibitor (ai) agent/regimen is permitted).
Description

Hormone Therapy Locally advanced breast cancer | Hormone Therapy Secondary malignant neoplasm of female breast | Aromatase Inhibitors Adjuvant Quantity allowed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C3495949
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C0346993
UMLS CUI [3,1]
C0593802
UMLS CUI [3,2]
C1522673
UMLS CUI [3,3]
C1265611
UMLS CUI [3,4]
C0683607
more than 1 prior chemotherapy regimen in locally advanced or metastatic breast cancer.
Description

Chemotherapy Regimen Quantity Locally advanced breast cancer | Chemotherapy Regimen Quantity Secondary malignant neoplasm of female breast

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C3495949
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0346993
adjuvant endocrine therapy <=12 months prior to day 1 of treatment.
Description

Hormone Therapy Adjuvant

Type de données

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C1522673
disease refractory (ie, progressive disease (pd) within 6 months from initiation of therapy) to previous adjuvant antiestrogen therapy.
Description

Prior antiestrogen therapy Adjuvant | Refractory Disease | Progressive Disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0279797
UMLS CUI [1,2]
C1522673
UMLS CUI [2]
C1514815
UMLS CUI [3]
C1335499
bone or skin as the only site of disease.
Description

Disorder by Site Bone only | Disorder by Site Skin only

Type de données

boolean

Alias
UMLS CUI [1,1]
C1333305
UMLS CUI [1,2]
C0262950
UMLS CUI [1,3]
C0205171
UMLS CUI [2,1]
C1333305
UMLS CUI [2,2]
C1123023
UMLS CUI [2,3]
C0205171
extensive visceral disease or active central nervous system (cns) disease.
Description

Disease Visceral Extensive | CNS disorder

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0442045
UMLS CUI [1,3]
C0205231
UMLS CUI [2]
C0007682
any other cancer within 5 years of screening with the exception of er+ contralateral breast carcinoma, adequately treated cervical carcinoma in situ, or adequately treated basal or squamous cell carcinoma of the skin.
Description

Cancer Other | Exception Contralateral Breast Carcinoma Estrogen receptor positive | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated

Type de données

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C3274709
UMLS CUI [2,3]
C0279754
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0007117
UMLS CUI [4,3]
C1522326
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0553723
UMLS CUI [5,3]
C1522326
major surgery or radiotherapy within 14 days of treatment day.
Description

Major surgery | Therapeutic radiology procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2]
C1522449
inadequate hepatic/renal/bone marrow function.
Description

Liver Dysfunction | Abnormal renal function | Bone Marrow function Inadequate

Type de données

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C0151746
UMLS CUI [3,1]
C0005953
UMLS CUI [3,2]
C0031843
UMLS CUI [3,3]
C0205412
history of clinically significant or uncontrolled cardiac disease.
Description

Heart Disease Clinical Significance | Heart Disease Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C2826293
UMLS CUI [2,1]
C0018799
UMLS CUI [2,2]
C0205318
serious concurrent illness.
Description

Comorbidity Serious

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205404
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT00880009

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Female Sterilization | Postmenopausal state
Item
surgically sterile or post-menopausal women.
boolean
C0015787 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
Breast Carcinoma
Item
confirmed pathologic diagnosis of breast cancer.
boolean
C0678222 (UMLS CUI [1])
Locally advanced breast cancer | Secondary malignant neoplasm of female breast | Breast cancer recurrent Local-Regional | Curative Surgery Unsuccessful | Therapeutic radiology procedure Curative Unsuccessful
Item
locally advanced or metastatic, or loco-regional recurrent breast cancer not amenable to curative treatment with surgery or radiotherapy.
boolean
C3495949 (UMLS CUI [1])
C0346993 (UMLS CUI [2])
C0278493 (UMLS CUI [3,1])
C1947913 (UMLS CUI [3,2])
C1511562 (UMLS CUI [4,1])
C1272705 (UMLS CUI [4,2])
C1522449 (UMLS CUI [5,1])
C1276305 (UMLS CUI [5,2])
C1272705 (UMLS CUI [5,3])
Estrogen receptor positive tumor Biopsy | Progesterone receptor positive tumor Biopsy | Neoplasm HER2/Neu Negative Biopsy
Item
documented er+ and/or pgr+ and erbb2- tumor based on most recently analyzed biopsy, as documented by a local laboratory.
boolean
C1562312 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C1562928 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
C0027651 (UMLS CUI [3,1])
C2348908 (UMLS CUI [3,2])
C0005558 (UMLS CUI [3,3])
Measurable lesion Quantity Radiography
Item
at least 1 radiologically measurable lesion as defined by response evaluation criteria in solid tumors (recist).
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0043299 (UMLS CUI [1,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
letrozole | Exception Adjuvant therapy | bosutinib | src inhibitors
Item
prior letrozole (except in adjuvant setting), prior bosutinib, or any other prior src inhibitor.
boolean
C0246421 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0677850 (UMLS CUI [2,2])
C1831731 (UMLS CUI [3])
C0282625 (UMLS CUI [4,1])
C0243077 (UMLS CUI [4,2])
Hormone Therapy Locally advanced breast cancer | Hormone Therapy Secondary malignant neoplasm of female breast | Aromatase Inhibitors Adjuvant Quantity allowed
Item
prior endocrine treatment for locally advanced or metastatic breast cancer (up to one prior adjuvant aromatase inhibitor (ai) agent/regimen is permitted).
boolean
C0279025 (UMLS CUI [1,1])
C3495949 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C0346993 (UMLS CUI [2,2])
C0593802 (UMLS CUI [3,1])
C1522673 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0683607 (UMLS CUI [3,4])
Chemotherapy Regimen Quantity Locally advanced breast cancer | Chemotherapy Regimen Quantity Secondary malignant neoplasm of female breast
Item
more than 1 prior chemotherapy regimen in locally advanced or metastatic breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C3495949 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0346993 (UMLS CUI [2,3])
Hormone Therapy Adjuvant
Item
adjuvant endocrine therapy <=12 months prior to day 1 of treatment.
boolean
C0279025 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
Prior antiestrogen therapy Adjuvant | Refractory Disease | Progressive Disease
Item
disease refractory (ie, progressive disease (pd) within 6 months from initiation of therapy) to previous adjuvant antiestrogen therapy.
boolean
C0279797 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
C1514815 (UMLS CUI [2])
C1335499 (UMLS CUI [3])
Disorder by Site Bone only | Disorder by Site Skin only
Item
bone or skin as the only site of disease.
boolean
C1333305 (UMLS CUI [1,1])
C0262950 (UMLS CUI [1,2])
C0205171 (UMLS CUI [1,3])
C1333305 (UMLS CUI [2,1])
C1123023 (UMLS CUI [2,2])
C0205171 (UMLS CUI [2,3])
Disease Visceral Extensive | CNS disorder
Item
extensive visceral disease or active central nervous system (cns) disease.
boolean
C0012634 (UMLS CUI [1,1])
C0442045 (UMLS CUI [1,2])
C0205231 (UMLS CUI [1,3])
C0007682 (UMLS CUI [2])
Cancer Other | Exception Contralateral Breast Carcinoma Estrogen receptor positive | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated
Item
any other cancer within 5 years of screening with the exception of er+ contralateral breast carcinoma, adequately treated cervical carcinoma in situ, or adequately treated basal or squamous cell carcinoma of the skin.
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C3274709 (UMLS CUI [2,2])
C0279754 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0553723 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
Major surgery | Therapeutic radiology procedure
Item
major surgery or radiotherapy within 14 days of treatment day.
boolean
C0679637 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Liver Dysfunction | Abnormal renal function | Bone Marrow function Inadequate
Item
inadequate hepatic/renal/bone marrow function.
boolean
C0086565 (UMLS CUI [1])
C0151746 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C0031843 (UMLS CUI [3,2])
C0205412 (UMLS CUI [3,3])
Heart Disease Clinical Significance | Heart Disease Uncontrolled
Item
history of clinically significant or uncontrolled cardiac disease.
boolean
C0018799 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Comorbidity Serious
Item
serious concurrent illness.
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial